text:
Department of Radiation oncology and experimental cancer research
751 – 1000 of 2201
- show: 250
- |
- sort: year (new to old)
Embed this list
<iframe src=""
- 2008
The Transforming Functions of PI3-kinase-gamma Are Linked to Disruption of Intercellular Adhesion and Promotion of Cancer Cell Invasion
2008) ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1138. p.204-213 Mark(
- Radical Hysterectomy following Intensity Modulated Arc Therapy (IMAT) in the Multimodality treatment of locally advanced cervical cancer
Cost-effectiveness of particle therapy: current evidence and future needs
2008) RADIOTHERAPY AND ONCOLOGY. 89(2). p.127-134 Mark(
The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields: the EORTC-GELA lymphoma group guidelines
2008) RADIOTHERAPY AND ONCOLOGY. 88(2). p.202-210 Mark(
Insulin-like growth factor-I receptor, E-cadherin and alpha v integrin form a dynamic complex under the control of alpha-catenin
2008) INTERNATIONAL JOURNAL OF CANCER. 122(3). p.572-582 Mark(
- Synthesis, biological evaluation and 2D-QSAR analysis of chalcones as anti-invasive cancer agents
The use of [I-123]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: In vitro R1M rabdomyosarcoma cell and in vivo mouse experiments
2008) CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 23(2). p.192-201 Mark(
Single-nucleotide polymorphisms in DNA double-strand break repair genes: Association with head and neck cancer and interaction with tobacco use and alcohol consumption
2008) MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS. 656(1-2). p.74-81 Mark(
- Antioxidant, Antiinflammatory and Antiinvasive Activities of Biopolyphenolics
Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies
2008) LANCET ONCOLOGY. 9(4). p.367-375 Mark(
Image-guided radiation therapy: Many roads lead to Rome?
2008) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 70(2). p.646-647 Mark(
Enhancement of PDGF-BB mitogenic activity on human dermal fibroblasts by biospecific dextran derivatives
2008) BIOMATERIALS. 29(14). p.2280-2292 Mark(
Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer
2008) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 71(4). p.1158-1166 Mark(
- Influence of neoadjuvant chemoradiation on surgical outcome following Ivor Lewis esophagectomy for cancer of the distal esophagus and gastric cardia
Internal exposure to pollutants measured in blood and urine of Flemish adolescents in function of area of residence
2008) CHEMOSPHERE. 71(7). p.1317-1325 Mark(
- In vivo quantitative proton magnetic resonance spectroscopy
Biomonitoring at the beginning of life to assess environmental factors influencing children's health
2008) TOXICOLOGY LETTERS. 180. p.S6-S7 Mark(
Transcriptome analysis in peripheral blood of humans exposed to environmental carcinogens: a promising new biomarker in environmental health studies
2008) EJC SUPPLEMENTS. 6(9). p.197-198 Mark(
The prenylated chalcone xanthohumol induces unfolded protein response, autophagy, and cell death in breast cancer cells by proteasome inhibition
2008) ANTICANCER RESEARCH. 28(5C). p.3525-3526 Mark(
- Synthesis, biological evaluation and 2D-QSAR analysis of chalcones as anti-invasive cancer agents
- Prognostic significance of pathological response to neoadjuvant chemoradiation in carcinoma of the esophagus and gastric cardia
On the calibration process of film dosimetry: OLS inverse regression versus WLS inverse prediction
2008) PHYSICS IN MEDICINE AND BIOLOGY. 53(14). p.3971-3984 Mark(
mBAND analysis of chromosome aberrations in lymphocytes exposed invitro to alpha-particles and gamma-rays
2008) INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. 84(6). p.447-453 Mark(
Cellular uptake of soy-derived phytoestrogens in vitro and in human whole blood
2008) Journal of Pre-Clinical and Clinical Research. 2(1). p.64-70 Mark(
Random walk simulation of R2-dispersion in foam microstructures
2008) IFMBE PROCEEDINGS. 22. p.2459-2463 Mark(
- Microstructural analysis of densely packed cells by use of diffusion simulations
Prevalence of apical periodontitis and associated coronal factors in head and neck irradiated patients.
2008) Endodontic practice today. 2(2). p.105-115 Mark(
Growth factor/peptide receptor imaging for the development of targeted therapy in oncology
2008) CURRENT PHARMACEUTICAL DESIGN. 14(31). p.3340-3347 Mark(
Stromal myofibroblasts are drivers of invasive cancer growth
2008) INTERNATIONAL JOURNAL OF CANCER. 123(10). p.2229-2238 Mark(
F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma - A case report
2008) Journal of Thoracic Imaging. 23(1). p.35-38 Mark(
The design of anisotropic diffusion phantoms for the validation of diffusion weighted magnetic resonance imaging
2008) PHYSICS IN MEDICINE AND BIOLOGY. 53(19). p.5405-5419 Mark(
Radiological properties of the PRESAGE and PAGAT polymer dosimeters
2008) APPLIED RADIATION AND ISOTOPES. 66(12). p.1970-1974 Mark(
Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck
2008) CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 23(1). p.25-33 Mark(
Multiplex genotyping as a biomarker for susceptibility to carcinogenic exposure in the FLEHS biomonitoring study
2008) CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 17(8). p.1902-1912 Mark(
Interobserver reproducibility in the interpretation of Tc-99m-labelled white blood cell scintigraphic images
2008) NUCLEAR MEDICINE COMMUNICATIONS. 29(12). p.1093-1099 Mark(
Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells
2008) MOLECULAR AND CELLULAR BIOLOGY. 28(3). p.1114-1123 Mark(
- Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with 3 different contrast agents for therapy monitoring in a tumour bearing mouse model.
Plant polyphenolics as anti-invasive cancer agents
2008) ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 8(2). p.171-185 Mark(
- Validation methods for diffusion weighted magnetic resonance imaging in brain white matter
The microbial PhIP metabolite 7-hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido[3 ',2 ': 4,5]imidazo[1,2-a]pyrimidin-5-ium chloride (PhIP-M1) induces DNA damage, apoptosis and cell cycle arrest towards Caco-2 cells
2008) TOXICOLOGY LETTERS. 178(1). p.61-69 Mark(
- Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells
A novel missense mutation (G43S) in the switch I region of Rab27A causing Griscelli syndrome
2008) MOLECULAR GENETICS AND METABOLISM. 94(2). p.248-254 Mark(
Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion
2008) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 72(3). p.799-807 Mark(
- Evidence behind use of intensity modulated radiotherapy: a systematic review of comparative clinical studies (vol 9, pg 367, 2008)
Pathological response in radical hysterectomy following intensity modulated arc therapy (IMAT) in the multimodality treatment of locally advanced cervical carcinoma
2008) HISTOPATHOLOGY. 53. p.193-194 Mark(
Gastrin releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry
2008) JOURNAL OF NUCLEAR MEDICINE. 49(2). p.260-264 Mark(
Sex ratio changes as sentinel health events of endocrine disruption
2008) INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH. 14(2). p.138-143 Mark(
Inter-observer reproducibility in reporting on renal drainage in children with hydronephrosis: a large collaborative study
2008) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 35(3). p.644-654 Mark(
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
2008) CANCER INVESTIGATION. 26(8). p.852-859 Mark(
- Development, external validation and further improvement of a prediction model for survival of non-small cell lung cancer patients treated with (Chemo)radiotherapy
Differential impact of TGF-β and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion
2008) CANCER LETTERS. 266(2). p.263-274 Mark(
NMR T2-relaxation as a tool for the characterisation of foam-like structures
2008) UGent-FirW Doctoraatssymposium, 9e. p.96-97 Mark(
Endocrine disruptors and abnormalities of pubertal development
2008) BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 102(2). p.168-175 Mark(
Monitoring, environment and perception. An experimental survey on health and environment in Flanders, Belgium
2008) International journal of global environmental issues. 8(1/2). p.90-111 Mark(
A single sample method for evaluating (51)Chromium-Ethylene diaminic tetraacetic acid clearance in normal and hyperthyroid cats
2008) JOURNAL OF VETERINARY INTERNAL MEDICINE. 22(2). p.266-272 Mark(
- 2007
- Xanthohumol: a new potential proteasome inhibitor that activates the pro-apoptotic arm of the unfolded protein response in B-CLL cells
Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro
2007) CANCER LETTERS. 255(1). p.57-70 Mark(
- IMAT: Remaining potentials
PCBs and PCDD/FS in fish and fish products and their impact on the human body burden in belgium
2007) ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY. 52(4). p.563-571 Mark(
Biomonitoring for genotoxic effects has a low sensitivity in terms of cancer risks associated with lifelong exposures starting in utero
2007) BIOMEDICINE & PHARMACOTHERAPY. 61(10). p.679-681 Mark(
The characterization and transmissibility of chromosome aberrations induced in peripheral blood lymphocytes by in vitro alpha-particle radiation
2007) RADIATION RESEARCH. 168(6). p.666-674 Mark(
Soluble cadherins as cancer biomarkers
2007) CLINICAL & EXPERIMENTAL METASTASIS. 24(8). p.685-697 Mark(
Radiolabelled chemotherapeutics
2007) QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 51(2). p.139-151 Mark(
The effect of pipamperone on the binding index of 123I-5I-R91150, a selective 5-HT2A receptor radioligand,in the canine brain
2007) EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 34(Suppl. 2). p.258-258 Mark(
- Dose-finding study using oxaliplatin in combination with fixed dose gemcitabin and radiotherapy in patients with locally advanced pancreatic or biliary tract cancer.
Does iohexol one day prior to radioiodine treatment, affect absorbed dose in hyperthyroid cats?
2007) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 34(Suppl. 2). Mark(
- Measurement of kidney function by calculation of fractional uptake of technetium-99m-dimercaptosuccinic acid in cats
- IMRT and focused radiotherapy
Mismatch of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnetate single photon emission computed tomography (SPECT) in a euthyroid multinodular goiter
2007) CLINICAL NUCLEAR MEDICINE. 32(1). p.6-8 Mark(
Tc-99m-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy
2007) QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 51(2). p.182-188 Mark(
- Quantifying the diffusion in an anisotropic fiber phantom
- Simulation and experimental verification of the diffusion in the interstitial space
The anti-invasive and proapoptotic effect of xanthohumol: potential use in cancer.
2007) Beer in Health and Desease Prevention. p.000-000 Mark(
- Radiogenomics in gynecological cancer patients
The influence of air cavities within the PTV on Monte Carlo-based IMRT optimization
2007) JOURNAL OF PHYSICS CONFERENCE SERIES. 74. p.U26-U33 Mark(
- Quantitative proton magnetic resonance spectroscopy without water suppression
A possible mechanism of peritoneal pH changes during carbon dioxide pneumoperitoneum
2007) SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 21(3). p.489-491 Mark(
Measurement of renal function by calculation of fractional uptake of technetium-99m dimercaptosuccinic acid in cats
2007) European Journal Nuclear Medicine. 34(Suppl. 2). p.394-394 Mark(
- Influence of iohexol on the outcome of I131 treatment in cats
Predicting risk of radiation-induced lung injury
2007) JOURNAL OF THORACIC ONCOLOGY. 2(9). p.864-874 Mark(
The influence of cooling rate on the accuracy of normoxic polymer gel dosimeters
2007) PHYSICS IN MEDICINE AND BIOLOGY. 52(10). p.2719-2728 Mark(
Edelfosine protects precultured heart fragments against the invasion of malignant cells through altered sialylation
2007) ONCOLOGY REPORTS. 17(2). p.433-439 Mark(
- The endoplasmic reticulum: A target for new anticancer drugs
Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac JNK-dependent signaling pathways in colon cancer cells
2007) CELLULAR SIGNALLING. 19(8). p.1722-1732 Mark(
Intestinal bacteria play a crucial role in the carcinogenic risk from 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
2007) ENVIRONMENTAL AND MOLECULAR MUTAGENESIS. 48(7). p.560-560 Mark(
Intraoperative high-dose-rate Brachytherapy (IBT) for locally unresectable intraabdominal malignancy
2007) ACTA CHIRURGICA BELGICA. 107(5). p.523-528 Mark(
Association of thyroid hormone concentrations with levels of organochlorine compounds in cord blood of neonates
2007) ENVIRONMENTAL HEALTH PERSPECTIVES. 115(12). p.1780-1786 Mark(
Estrogen receptor alpha (ER alpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alpha T3-1 cell line
2007) JOURNAL OF CELLULAR PHYSIOLOGY. 212(3). p.583-590 Mark(
Does regional brain perfusion correlate with eating disorder symptoms in anorexia and bulimia nervosa patients?
2007) JOURNAL OF PSYCHIATRIC RESEARCH. 41(12). p.1005-1011 Mark(
Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer
2007) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 68(1). p.126-135 Mark(
Monte Carlo treatment planning for photon and electron beams
2007) RADIATION PHYSICS AND CHEMISTRY. 76(4). p.643-686 Mark(
The value of EDR2 film dosimetry in compensator-based intensity modulated radiation therapy
2007) PHYSICS IN MEDICINE AND BIOLOGY. 52(19). Mark(
- Validation of diffusion imaging with anisotropic fiber phantom
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma
2007) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 67(1). p.19-30 Mark(
VE/VCO2 slope and oxygen uptake efficiency slope in patients with coronary artery disease and intermediate VO2max
2007) ACTA CARDIOLOGICA. 62(1). p.99-99 Mark(
Intensity modulating and other radiation therapy devices for dose painting
2007) JOURNAL OF CLINICAL ONCOLOGY. 25(8). p.924-930 Mark(
In regards to Allen et al. (Int J radiat oncol biol phys 2006;65: 640-645)
2007) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 68(1). p.315-316 Mark(
- Deguelin inhibits expression of I kappa B alpha protein and induces apoptosis of B-CLL cells in vitro
Lipoplex-loaded microbubbles for gene delivery: A Trojan horse controlled by ultrasound
2007) ADVANCED FUNCTIONAL MATERIALS. 17(12). p.1910-1916 Mark(
Xanthohumol induces in vitro apoptosis in B-CLL cells mediated by non-classical ER stress
2007) ACTA CLINICA BELGICA. 62(4). p.252-252 Mark(
- Squamous cell carcinoma of the anus: a possible target for EGFR inhibition?
Converging expression profiles from esophageal and colorectal cancer tissues: a comparative analysis using expression microarray.
2007) Gastrointestinal Cancers Symposium. p.441-441 Mark(
- The use of ketoconozale to improve the dog's brain uptake of the serotonin 2A-receptor radioligand I-123-R91150
Comparison of 6 MV and 18 MV photons for IMRT treatment of lung cancer
2007) RADIOTHERAPY AND ONCOLOGY. 82(1). p.63-69 Mark(
Conversion of CT numbers into tissue parameters for Monte Carlo dose calculations: a multi-centre study
2007) PHYSICS IN MEDICINE AND BIOLOGY. 52(3). p.539-562 Mark(
The use of ketoconozale to improve the dog's brain uptake of the 5-HT-2A receptor radioligand 123I-R-91150
2007) EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 34(Suppl. 2). p.397-397 Mark(
The need to develop centers for environmental oncology
2007) BIOMEDICINE & PHARMACOTHERAPY. 61(10). p.614-622 Mark(
- Invloed van industriële chemicaliën op de neurologische en neuropsychologische ontwikkeling van jonge kinderen.
- Radiochromic EBT film dosimetry: Effect of film orientation and batch on the lateral correction of the scanner.
A possible mechanism of peritoneal pH changes during carbon dioxide pneumoperitoneum
2007) SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 21(12). p.2344-2344 Mark(
- Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis
Validation of a resolution-independent method for the quantification of I-123-FP-CIT SPELT scans
2007) NUCLEAR MEDICINE COMMUNICATIONS. 28(10). p.771-774 Mark(
Checking the consistency of the two blood samples slope-intercept method for estimating GFR using the single blood sample formula in children
2007) NUCLEAR MEDICINE COMMUNICATIONS. 28(1). p.49-54 Mark(
Implementation of biologically conformal radiation therapy in the clinic
2007) RADIOTHERAPY AND ONCOLOGY. 84. p.S90-S90 Mark(
- Waiting times in the radiotherapy department in gent
- The use of HiSPECT in the investigation of the 5-HT2A receptor and DAT status in the Mongolian gerbil
- PAQAP: a quality assessment protocol for MRI
Intensity-modulated radiation therapy for head and neck carcinoma
2007) ONCOLOGIST. 12(5). p.555-564 Mark(
An overview of 50 patients who underwent epilepsy surgery at Ghent University Hospital
2007) EUROPEAN JOURNAL OF NEUROLOGY. 14(suppl. 1). p.83-83 Mark(
- Microbial and dietary factors associated with the equaol and 8-prenylnaringenin poducer phenotypes
- Role of adhesion molecules in locoregional cancer spread.
- Simulation of the diffusion in the interstitial space of a fiber phantom
- Quantitative proton magnetic resonance spectroscopy in presence of sidebands
The new EANM paediatric dosage card
2007) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 34(5). p.796-798 Mark(
Der Wissenschaftler Friedrich II. (der Staufer)
2007) Baden-Württembergisches Ärzteblatt. 05. p.274-276 Mark(
- Evaluation of pinpoint properties and central electrode material in clinical beam dosimetry by MC calculations
Akt1 & 2 depletion by RNA interference reduced tumor growth and invasion in human colon cancer cells
2007) ANNALS OF ONCOLOGY. 18. Mark(
Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha 1-integrins during colon cancer cell invasion
2007) INTERNATIONAL JOURNAL OF ONCOLOGY. 31(6). p.1501-1508 Mark(
Dosimetric characterization of GafChromic EBT film and its implication on film dosimetry quality assurance
2007) PHYSICS IN MEDICINE AND BIOLOGY. 52(14). p.4211-4225 Mark(
Precautions and strategies in using a commercial flatbed scanner for radiochromic film dosimetry
2007) PHYSICS IN MEDICINE AND BIOLOGY. 52(1). p.231-242 Mark(
(99m)Tc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy
2007) Q J Nucl Med Mol Imaging. 51. p.182-188 Mark(
- Radiation dosimetry in lung equivalent regions by use of polymer gel foams and quantitative magnetization transfer imaging
- MR engineering research at the Ghent University
Measurement techniques, Modeling strategies and pitfalls to avoid when implementing a mini MLC in a non dedicated planning system
2007) STRAHLENTHERAPIE UND ONKOLOGIE. 183(11). p.637-644 Mark(
Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
2007) BRITISH JOURNAL OF CANCER. 96(5). p.692-700 Mark(
Microstructural analysis of foam-like structures by use of R2 dispersion
2007) Proc. Intl. Soc. Mag. Reson. Med.. p.37-37 Mark(
- Culture of bovine in vitro embryos in the WOW system seems to prevent apoptosis at the blastocyst stage
- Converging expression profiles from oesophageal and colorectal cancer tissues: a comparative analysis using expression microarray.
- The effect of pipamperone on the binding index of 123I-5I-R91150, a selective 5-HT2A receptor radioligand, in the canine brain
Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy post-menopausal Caucasian women
2007) BRITISH JOURNAL OF NUTRITION. 98(5). p.950-959 Mark(
- QSAR directed design, synthesis and evaluation of anti-invasive chalcones and related heterocyclic compounds
- Biologically conformal radiation therapy and Monte Carlo dose calculations in the clinic
Cell motility and breast cancer metastasis.
2007) Metastasis of Breast Cancer.. p.47-75 Mark(
The use of magnetic sensors to monitor moderate deep inspiration breath hold during breast irradiation with dynamic MLC compensators
2007) RADIOTHERAPY AND ONCOLOGY. 82(3). p.341-348 Mark(
Drug trials in humans: Risks in the light of the London catastrophe
2007) Internist (Berl). 48(6). p.636-641 Mark(
The tandem PDZ domains of syntenin promote cell invasion
2007) EXPERIMENTAL CELL RESEARCH. 313(9). p.1790-1804 Mark(
- Chronische vermoeidheid en het binnenhuismilieu.
Efficiently updating and tracking the dominant kernel principal components
2007) NEURAL NETWORKS. 20(2). p.220-229 Mark(
Evaluation of uncertainty-based stopping criteria for Monte Carlo calculations of intensity-modulated radiotherapy and arc therapy patient dose distributions
2007) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 69(2). p.628-637 Mark(
Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: The need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity
2007) RADIOTHERAPY AND ONCOLOGY. 84(2). p.156-163 Mark(
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer
2007) ANNALS OF SURGICAL ONCOLOGY. 14(2). p.424-431 Mark(
Differences of cortical 5-HT2A receptor binding index with SPECT in subtypes of anorexia nervosa: Relationship with personality traits?
2007) JOURNAL OF PSYCHIATRIC RESEARCH. 41(5). p.455-458 Mark(
Regional variations in semen quality of community-dwelling young men from Flanders are not paralleled by hormonal indices of testicular function
2007) JOURNAL OF ANDROLOGY. 28(3). p.435-443 Mark(
Monte Carlo modeling of the ModuLeaf miniature MLC for small field dosimetry and quality assurance of the clinical treatment planning system
2007) PHYSICS IN MEDICINE AND BIOLOGY. 52(11). p.3275-3290 Mark(
Reproductive parameters of community-dwelling men from 2 regions in flanders are associated with the consumption of self grown vegetables
2007) JOURNAL OF ANDROLOGY. 28(6). p.836-846 Mark(
- Imaging of the serotonin-2A receptor before and after pipamperone administration in the canine brain
Estrogen receptor signaling is an unstable feature of the gonadotropic LβT2 cell line
2007) MOLECULAR AND CELLULAR ENDOCRINOLOGY. 273(1-2). p.16-24 Mark(
- A systematic comparison of absolute quantification schemes for proton magnetic resonance spectroscopy in presence of standing waves
- Absolute quantification of carnosine in human calf muscle by proton magnetic resonance spectroscopy
Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control
2007) RADIOTHERAPY AND ONCOLOGY. 82(2). p.160-166 Mark(
- Assessment of therapy response by DCE-MRI with a macromolecular gadolinium contrast agent.
Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning
2007) EUROPEAN JOURNAL OF RADIOLOGY. 63(3). p.361-368 Mark(
Absolute quantification of carnosine in human calf muscle by proton magnetic resonance spectroscopy
2007) PHYSICS IN MEDICINE AND BIOLOGY. 52(23). p.6781-6794 Mark(
- Three dimensional polymer gel dosimetry: State of the art
- Microstructural analysis of foam-like structures by use of R2 dispersion
- Absolute quantification of carnosine in human calf muscle by proton magnetic resonance spectroscopy
- Radiation of the rat brain suppresses seizure-induced Neurogenesis and transiently enhances excitability during kindling acquisition
The use of HiSPECT in the investigation of the 5-HT2A receptor and DAT status in the gerbil
2007) EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 34(Suppl. 2). p.158-158 Mark(
Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women
2007) JOURNAL OF NUTRITION. 137(10). p.2242-2246 Mark(
- 2006
Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines
2006) RADIOTHERAPY AND ONCOLOGY. 79(3). p.270-277 Mark(
Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer
2006) EUROPEAN RESPIRATORY JOURNAL. 27(5). p.895-901 Mark(
The fundamental radiation properties of normoxic polymer gel dosimeters: a comparison between a methacrylic acid based gel and acrylamide based gels
2006) PHYSICS IN MEDICINE AND BIOLOGY. 51(3). p.653-673 Mark(
Serotonin-2A binding index of the 5-HT2A receptor in dogs with anxiety disorder
2006) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33(suppl. 2). p.293-293 Mark(
Comparison among tomographic radionuclide ventriculography algorithms for computing left and right ventricular normal limits
2006) JOURNAL OF NUCLEAR CARDIOLOGY. 13(5). p.675-684 Mark(
Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction
2006) EUROPEAN JOURNAL OF HEART FAILURE. 8(3). p.275-277 Mark(
- Implementation and validation of an add-on MLC for Monte Carlo dose calculations in conformal stereotactic radiosurgery
- Biologische landbouw is belangrijk voor de volksgezondheid
E-cadherin regulates human Nanos1, which interacts with p120ctn and induces tumor cell migration and invasion
2006) CANCER RESEARCH. 66(20). p.10007-10015 Mark(
Sequential Tc-99m-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy
2006) JOURNAL OF NUCLEAR MEDICINE. 47(11). p.1813-1818 Mark(
Pediatric applications of renal nuclear medicine
2006) SEMINARS IN NUCLEAR MEDICINE. 36(1). p.16-35 Mark(
- Removal of sideband modulations in 1H MRS without solvent suppression
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model
2006) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 64(4). p.1188-1196 Mark(
Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering
2006) TISSUE ENGINEERING. 12(10). p.2707-2716 Mark(
Anti-invasive and anti-metastasis strategies: New roads, new tools and new hopes
2006) CURRENT CANCER DRUG TARGETS. 6(8). p.729-751 Mark(
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicity
2006) RADIOTHERAPY AND ONCOLOGY. 80(1). p.78-81 Mark(
Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin's lymphoma
2006) NUCLEAR MEDICINE COMMUNICATIONS. 27(10). p.753-756 Mark(
Early prediction of endocrine therapy effect in advanced breast cancer patients using Tc-99m-depreotide scintigraphy
2006) JOURNAL OF NUCLEAR MEDICINE. 47(1). p.6-13 Mark(
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy (HART) in resectable distal rectal cancer
2006) Gastrointestinal Cancers Symposium, Abstracts. p.352-352 Mark(
- Ki-67 and von Willebrand factor: outcome predictors for oesophageal cancer
2006) International Journal of Gynecological Cancer. p.580-581 Mark(
Bioavailability of phytoestrogens from soy and hops
2006) Reproduction Nutrition Development. 46(S1). Mark(
- Pro-invasive molecular cross-signaling between cancer cells and myofibroblasts
Tumour markers in andrology
2006) Andrology for the Clinician. p.415-425 Mark(
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy (HART) in resectable distal rectal cancer
2006) ANNALS OF ONCOLOGY. 17(suppl. 1). Mark(
Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations
2006) MEDICAL PHYSICS. 33(9). p.3149-3158 Mark(
- Neurohumoral and inflammatory activation in patients with coronary artery disease treated with statins
Definition and delineation of the clinical target volume for rectal cancer
2006) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 65(4). p.1129-1142 Mark(
An expert system for the detection of renal obstruction
2006) JOURNAL OF NUCLEAR MEDICINE. 47(8). p.1394-1394 Mark(
Synthesis and evaluation of a (99m)Technetium labeled chitin-binding protein as potential specific radioligand for the detection of fungal infections in mice
2006) QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 50(3). p.155-166 Mark(
Three dimensional radiation dosimetry in lung-equivalent regions by use of a radiation sensitive gel foam: Principles
2006) Journal of Physics: Conference Series. 56. p.256-258 Mark(
QSAR modeling of anti-invasive activity of organic compounds using structural descriptors
2006) BIOORGANIC & MEDICINAL CHEMISTRY. 14(20). p.6933-6939 Mark(
- Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro
Brain imaging tools in neurosciences
2006) JOURNAL OF PHYSIOLOGY-PARIS. 99(4-6). p.281-292 Mark(
- Pregabalin in central neuropathic pain associated with spinal cord injury - A placebo-controlled trial
- Intensity-modulated radiotherapy (IMRT) as primary therapy for prostate cancer: The experience of the Ghent University Hospital (GUH).
- Modelling the diffusion in the interstital space of a fiber phantom
- Phantom design for diffusion tensor magnetic resonance imaging
Relationship between PCBs, dioxins, chlorinated pesticides and fertility problems in young women.
2006) Epidemiology. 17. p.S193-S193 Mark(
Serum dioxin-like activity is associated with reproductive parameters in young men from the general Flemish population
2006) ENVIRONMENTAL HEALTH PERSPECTIVES. 114(11). p.1670-1676 Mark(
Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma
2006) CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. 84(10). p.1021-1028 Mark(
Post-test quality control for the single blood sample technique in glomerular filtration rate measurement in children
2006) NUCLEAR MEDICINE COMMUNICATIONS. 27(3). p.255-260 Mark(
- Neoadjuvant chemoradiation versus hyperfractionated accelerated radio-therapy (HART) in respectable dital rectal cancer
- Intensity modulated radiation therapy and arc therapy: validation and evolution as applied to tumours of the head and neck, abdominal and pelvic regions
- The N-cadherin ectodomain: fate and finction outside the cancer cell
VE/Vco(2) slope and oxygen uptake efficiency slope in patients with coronary artery disease and intermediate peakVo(2)
2006) EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION. 13(6). p.916-923 Mark(
Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly in cells
2006) JOURNAL OF CELL SCIENCE. 119(9). p.1947-1960 Mark(
Implementation of biologically conformal radiation therapy (BCRT) in an algorithmic segmentation-based inverse planning approach
2006) PHYSICS IN MEDICINE AND BIOLOGY. 51(16). Mark(
- Role of adipocyte-derived resistin in breast cancer
Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric G alpha/G beta gamma protein complex
2006) CANCER RESEARCH. 66(18). p.9227-9234 Mark(
Revisiting normal Cr-51-ethylenediaminetetraacetic acid clearance values in children
2006) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33(12). p.1477-1482 Mark(
Synthesis of Tc-99m-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes
2006) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33(4). p.474-482 Mark(
- Functional renal imaging in cats using 99mTc-DMSA
Glomerular filtration rate measurement in cats with a single-injection method using chromium-51 ethylene diaminic tetra-acetic acid.
2006) Proceedings of the 16th ECVIM-CA conference. p.187-187 Mark(
- Unravelling the biological base of behaviour: the role of spect modalities
- 2D-3D methods for clinical dose verification
- MLC based stereotactic radiosurgery: The accuracy of the collapse cone algorithm of pinnacle 7.4 modelled and controlled using a consistent data set obtained by several independent detectors.
- Accuracy of patient dose calculations for IMRT treatment of lung cancer
- Optimized segment-aperture mono-arctherapy (OSAMAT) and its application in conformal radiation of oligometastatic prostate cancer: A phase I study.
VE/VCO2 slope and oxygen uptake efficiency Sslope in patients with coronary artery disease and intermediate VO2max
2006) EUROPEAN HEART JOURNAL. 27. p.97-97 Mark(
Flemish serum values of organochlorinated compounds: where are we now? First results of Flemish environment and health survey (FLEHS) 2002-2006
2006) ORGANOHALOGEN COMPOUNDS. 68. p.1615-1618 Mark(
The Flemish health and environment biomonitoring prgram: relation between PCB levels in cord blood and dietary habits
2006) ORGANOHALOGEN COMPOUNDS. 68. p.1505-1508 Mark(
Study of density and stability of a lung-equivalent gel
2006) Journal of Physics: Conference Series. 56. p.149-152 Mark(
Soluble N-cadherin fragment promotes angiogenesis
2006) CLINICAL & EXPERIMENTAL METASTASIS. 23(3-4). p.187-201 Mark(
TGF beta 1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors
2006) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 65(4). p.1240-1248 Mark(
Comparative biodistribution study of the new tumor tracer [I-123]-2-iodo-L-phenylalanine with [I-123]-2-iodo-L-tyrosine
2006) NUCLEAR MEDICINE AND BIOLOGY. 33(1). p.111-117 Mark(
Diabetes and impaired fasting glucose as predictors of morbidity and mortality in male coronary artery disease patients with reduced left ventricular function
2006) ACTA CARDIOLOGICA. 61(2). p.137-143 Mark(
Differences in tumor-associated protein levels among middle-age Flemish women in association with area of residence and exposure to pollutants
2006) ENVIRONMENTAL HEALTH PERSPECTIVES. 114(6). p.887-892 Mark(
- Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells
Y-90-lbritumomab tiuxetan: new drug, interesting concept, and encouraging in practice
2006) NUCLEAR MEDICINE COMMUNICATIONS. 27(7). p.595-596 Mark(
- What precautions should we use with a flatbed scanner for radiochromic film dosimetry
- A single sample 51Cr-EDTA clearance for the early detection of renal dysfunction in cats
Are von Willebrand factor and Ki-67 outcome predictors for esophageal cancer?
2006) ANNALS OF ONCOLOGY. 17(suppl. 6). p.49-49 Mark(
- Re-188-HDD/Lipiodol for hepatocellular carcinoma: our experience with the first 100 treatments.
Soluble N-cadherin in human biological fluids
2006) INTERNATIONAL JOURNAL OF CANCER. 119(12). p.2895-2900 Mark(
Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock
2006) FASEB JOURNAL. 20(13). Mark(
Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents
2006) APPLIED RADIATION AND ISOTOPES. 64(6). p.677-685 Mark(
Serotonin transporter and dopamine transporter imaging in the canine brain
2006) NUCLEAR MEDICINE AND BIOLOGY. 33(7). p.907-913 Mark(
Functional imaging, serotonin and the suicidal brain
2006) ACTA NEUROLOGICA BELGICA. 106(3). p.125-131 Mark(
Correction factors after having neglected the first exponential in the estimation of chromium-51 EDTA clearance: a reappraisal
2006) ANNALS OF NUCLEAR MEDICINE. 20(2). p.95-98 Mark(
Cat brain perfusion with multi-pinhole SPECT imaging
2006) European Journal of Nuclear Medicine and Molecular Imaging. 33. p.285-285 Mark(


text:
Dollar's Prospects Are Cloudy Amid Continuing Asian Crisis
NEW YORK -- Contradictory impulses from Asia's financial crisis will combine with unease over East Europe to muddy the outlook for the dollar this week.
The U.S. currency usually gains on its status as a safe haven from international turmoil, but worries Asia's woes will cut into U.S. corporate profits enough to send stocks tumbling could push the dollar in the opposite direction, analysts said.
Heightened concerns South Korea...

subset: commoncrawl


text:
Two vastly different bills before Congress, which seek to establish a new Department of Homeland Security (DHS), will have significantly different five-year costs, according to the Congressional Budget Office (CBO). Implementing President Bush's plan, for example, will cost the American taxpayer about $3.3 billion, while a bill introduced by Senate Governmental Affairs Committee Chairman Joseph Lieberman (D-CT) will cost about $10.7 billion. Both bills include measures of merit, such as the National Bio-Weapons Defense Analysis Center, and measures that may limit the overall effectiveness of the federal effort. But the President's bill offers the nation more flexibility and efficiency in improving homeland security as well as savings of at least $7 billion through 2007, compared to the Senate bill.
On June 24, President George W. Bush offered Congress a structure for the new department that focuses on consolidating existing federal functions to improve the efficiency and effectiveness of federal programs.2 He also notified Congress that he intended to pay for this massive reorganization of the government with funds he included in his fiscal year 2003 budget request.3 As the experience of private-sector mergers and acquisitions shows, the President's approach should increase the effectiveness of federal homeland security programs and also reduce overhead costs associated with bureaucracy. The House passed a modified version of the President's plan (H.R. 5005) on July 26.
That same day, however, the Senate Governmental Affairs Committee passed out a bill (S. 2452) that takes a different, more costly approach. The bill's language would prevent the President or Secretary of Homeland Security from consolidating any programs or functions that are transferred to the new department. S. 2452 also adds numerous new programs to the department, including some that are not directly related to and would not directly improve homeland security, such as repairing Amtrak's cars and tunnels.
The differences between these two approaches will dramatically affect the total cost of implementing and operating the new department. Overall, the Congressional Budget Office estimates that, between fiscal years 2003 and 2007, implementing S. 2452 will cost approximately $10.7 billion, about $7 billion more than the President's proposal ($3.3 billion). In addition, the Senate bill includes a prohibition on consolidating redundant federal roles, which is likely to increase overhead costs significantly while reducing the department's overall effectiveness in the foreseeable future.
Congress should provide a solid foundation for the new department that would not only improve security but also would reduce the total cost of the homeland security effort. Specifically, Congress should allow the Secretary of DHS to consolidate redundant and overlapping federal agencies and programs that are transferred to the new department, and it should refrain from adding numerous new programs, particularly any that clearly will not improve security against terrorism. S. 2452 fails to do either and, in its current version, will cost billions of dollars more over the next five years than would the President's plan.
Two different Approaches to Creating a DHS
On the same day that the Senate's Governmental Affairs Committee approved the costly S. 2452, the U.S. House of Representatives passed the National Homeland Security Act of 2002 (H.R. 5005), which was based on and still closely mirrors the President's initial proposal. The approach seeks to reduce redundancy and improve efficiency by consolidating many of the homeland security functions that are currently spread throughout the federal government. Among the many changes made to the bill during the legislative process, however, are detrimental provisions that would prevent the consolidation of the Customs Service and the United States Coast Guard--two of the most important agencies for border security--into the proposed DHS Directorate of Border and Transportation Security.
S. 2452, the National Homeland Security and Combating Terrorism Act introduced by Senator Lieberman that is currently being debated by the full Senate as a substitute to H.R. 5005, offers a radically different structure for the new DHS. It includes billions of dollars of new spending on many additional programs that are either unnecessary or unrelated to homeland security, and it severely limits the proposed Secretary of Homeland Security's authority to eliminate fragmentation among the programs transferred to the new department.
Such differences in the two approaches are significant, and will have a massive effect on the costs of both reorganizing the federal government for homeland security and running the new department in the foreseeable future.
CBO's Cost Estimates
This summer, the Congressional Budget Office reviewed both the President's proposed legislation (introduced as H.R. 50054) and the bill passed by the Senate Government Affairs Committee (S. 24525). CBO's scoring of S. 2452 shows an implementation cost between fiscal years 2003 and 2007 of almost $10.7 billion, compared with a cost of about $3.3 billion to implement the President's plan.
Both estimates are of spending that is beyond what CBO projects the federal government would have spent on the current federal activities transferred to the new department. The baseline estimates for these other activities were $31 billion for the President's proposal, and $33 billion for the department under S. 2452. CBO's estimates do not include additional funds designed to improve the effectiveness of the existing programs, nor does the CBO estimate account for potential savings due to efficiency gains through the President's proposal.
Most of the additional cost of S. 2452 would come from the new programs and policies that the Senate Government Affairs Committee wants to add to the President's request. Between 2003 and 2007, CBO estimates that these new programs would increase spending by about $9.6 billion. (See Table 1.) Of this amount, $1.9 billion would be for the Directorate for Science and Technology, $1.1 billion for new refugee and asylum adjudication and ombudsman programs in the Directorate for Immigration Affairs, and $1.2 billion for grants to Amtrak (mostly for programs unrelated to security, with other programmatic costs being distributed throughout the department).
Most of CBO's estimated $3.3 billion in additional spending over that period for new programs in the President's proposal would be used to establish a National Bio-Weapons Defense Analysis Center, also an element of S. 2452.


text:
Hide Images
1In large bowl, mix potatoes, eggs, cheese, Bisquick mix and garlic salt.
2In 12-inch skillet, heat 2 tablespoons of the oil over medium heat. For each patty, spoon about 1/2 cup potato mixture into oil in skillet. Flatten with the back of spatula.
3Cook patties about 4 minutes, turning once, until golden brown. Remove from skillet and cover to keep warm while cooking remaining patties. Add remaining 2 tablespoons oil as needed to prevent sticking.
4In 2-quart saucepan, heat corn, beans and salsa over medium heat 2 to 3 minutes, stirring occasionally, until hot. Serve over patties. Top with sour cream.


text:
Patient : I am 24 years old, and weigh 165lbs. I dont have alot of muscle mass, but everyone tells me that I am the strongest person they know. I can lift a couch over my head by myself, and I can lift a refrigerator over my head by myself. I can also lift the back end of a car off the ground. I want to know what is making me so strong? Because, like I said I dont have a lot of muscle mass, so I am wondering if it could be something else making me so strong.
Doctor : This question is currently in queue and will be answered shortly by one of our doctors. In the meantime you may browse our library of answered questions by clicking here.
Related Q&A
I am a very good singer, I am a man
Q: I am a very good singer, I am a man that is 17 years old. But this time, I am always clearing my throat as I always f...
Frequent and unusual numbness
Q: I am 33 years old, and have an issue with hands and legs becoming numb so fast with the slightest discomfort when my ...
Why am I weaker than most persons my age?
Q: I'm a lot weaker than everyone else my age. How can I not be?
Hypoglycemic after 8 month Bodybuilding Contest Prep Diet?
Q: I just finished a long 8 month bodybuilding contest diet and was down to extremely low carbs and almost no sugar duri...
Neck pain when doing push ups
Q: This needs a short intro. I have been doing push ups since quite a time. Someone told me to do push ups while lookin...
Dr. James Obaji M.D.
- 247 Reviews
- Family Physician
Dr. Suneel Sharman M.D.
- 190 Reviews
- Family Physician
Dr. Pat Golden M.D.
- 169 Reviews
- Cardiologist
Dr. Kunaal Jindal M.D.
- 112 Reviews
- Plastic Surgeon


text:
Whether you're picking out wine for a large wedding or preparing a simple meal for dinner club, we've got you covered with food & wine pairing tips, insider secrets, and even a few great words to get the party started right. Cheers!
Event Planning:
- Best Bets for Mini-Champagne and Sparkling Wine Bottles
- Toast the New Year with Sparkling Wines from Around the World
- Ten Wicked Wines for Halloween
- Best Bets for Budget Wedding Bubbly
- Somm Things I Think About: Pop the Cork!
Check out all Event Planning posts HERE
Food & Wine:
- Wine Guide: Best Wines with Seafood
- Pairing Wine and Chocolate – Tips and Tricks
- 9 Ways to Make the Most of Your Party Leftovers
- Thanksgiving Wine and Pie Pairings
- Sicily: A food and wine paradise
Check out all Food & Wine posts HERE
Tips & Tricks:
- Pairing Wine and Chocolate – Tips and Tricks
- 9 Ways to Make the Most of Your Party Leftovers
- Somm Things I Think About: Easy wine sauces for easy wine pairings
- How to navigate Bordeaux on a budget
- 7 surprising uses for your leftover red wine
Check out all Tips & Tricks posts HERE


text:
Siobhán's late strike wins it for Wexford
Wexford made the long journey to foggy Dooradoyle on Sunday afternoon and got their FAI Inter-League campaign off to a winning start when they scored a late winner.
Limerick and District League 1 Wexford and District League 2
Both sides produced some top-class football and it was evident from early on that there was going to be little between the sides. Both goalkeepers performed excellently, and Wexford's Gráinne McCabe produced a player of the match display.
After a scoreless first-half, Wexford eventually broke the deadlock when Siobhán Doolan scored early in the second-half after some good build-up play, but the home side battled back and levelled with just 15 minutes of the match remaining.
As it looked as if both sides might have to settle for a point each, Siobhán Doolan got on the end of a Natasha Byrne cross to score in the 90th minute and earn Wexford an opening day win.
Well done to manager Alan Browne and his team of coaches, and of course the players who produced a great performance despite having such a short time to prepare.
Squad: Gráinne McCabe, Alannah Anglim, Lauren Roche, Chloe Mythen, Chloe Moynihan, Linda Bradley, Aisling O'Gorman, Natasha Byrne, Niamh Browne, Britney Conroy, Siobhán Doolan, Leah Furlong, Laura Rice, Meghan Kane, Rachel Scannell, Doireann Kavanagh, Sandra Murphy.
Wexford People


text:
Thank you for your willing and unselfish sacrifice for my undeserved freedom of religion in America!
It seems to me that most Americans, including many Baptists, are either unaware or have forgotten the extraordinary role that Baptists played in securing religious liberty in America. Many Americans who are aware seek to minimize Christianity's role in general and Baptist's role in particular. Then there are those whose lack of acknowledgement and appreciation sometimes manifests itself in admonishments to pastors, particularly Baptist pastors, against speaking out or being involved in politics. Some of these chastisements come from Baptist pews and pulpits. Let me mention one historical example of Baptist influence. Continue reading →


text:
Saif Ali Khan and Esha Gupta approached for a film?
If sources are to be believed then Saif Ali Khan and Esha Gupta have been approached for a film together.
Saif Ali Khan and Esha Gupta
Kunal Kohli is producing the film and is also acting in it, while Danish Aslam will apparently be helming the project.
A source said, "Kunal wanted to direct the film, but since he is acting also in the film, he thought it would be better if he produces the film. Danish Aslam and Kunal Kohli were wanting to work together from a long time. So now Kunal agreed to produce the film, whereas Danish will be directing it."
"They have approached Saif Ali Khan and Esha Gupta to play the lead roles," the source added.


text:
Transpulmonary Thermodilution and Transesophageal Echocardiography in Early Septic Shock (HEMOSEPSIS)
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2010 by University Hospital, Limoges.
Recruitment status was: Recruiting
Recruitment status was: Recruiting
University Hospital, Limoges
ClinicalTrials.gov Identifier:
First Posted: August 26, 2010
Last Update Posted: November 1, 2013
Information provided by (Responsible Party):
University Hospital, Limoges
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Detailed Description:
The purpose of this study is to assess the concordance of therapeutic changes proposed after an early hemodynamic evaluation (hemodynamic profile) in septic shock patients using jointly the transpulmonary thermodilution technique and transesophageal echocardiography (TEE).
|Septic Shock
|Other: early septic shock
|Phase 3
|Study Type:
|Study Design:
|Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
|Official Title:
|Hemodynamic Assessment With Transpulmonary Thermodilution and Transesophageal Echocardiography in Patients With Early Septic Shock
Resource links provided by NLM:
MedlinePlus related topics: ShockU.S. FDA Resources
Further study details as provided by University Hospital, Limoges:
Primary Outcome Measures:
- therapeutic procedure following the hemodynamic assessment [ Time Frame: 2 years ]Changes in therapy proposed after the hemodynamic assessment (hemodynamic profile) by each of the two tested methods: blood volume expansion (preload responsiveness), positive inotrope (cardiac dysfunction), vasopressor (vasoplegia), no change in ongoing therapy or dose tapering (inotropes or vasopressor).
Secondary Outcome Measures:
- efficacy and safety of therapeutic intervention [ Time Frame: 2 years ]Efficacy (clinical problem solved) and tolerance (potential side-effects) of the therapeutic change.
|Estimated Enrollment:
|Study Start Date:
|January 2011
|Estimated Study Completion Date:
|December 2014
|Estimated Primary Completion Date:
|January 2014 (Final data collection date for primary outcome measure)
|Assigned Interventions
septic shock
Each patient will be assessed by both the transpulmonary thermodilution technique and TEE.
Other: early septic shock
Each patient will be assessed by both the transpulmonary thermodilution and Transesophageal Echocardiography.
Detailed Description:
Each patient will be assessed by both the transpulmonary thermodilution technique and TEE (H0). The two assessments will be performed in random order (central randomization stratified by participating center), but within 30 minutes (no change of ongoing treatment during the assessment period). Two investigators not involved in patient care and blinded to the results of the alternative technique will performed independently the hemodynamic assessment using one of the two modalities for hemodynamic assessment tested in the study. They will interpret the results at bedside and propose a therapeutic change to the attending physician, according to the hemodynamic profile. The latter will finally: precisely identify the clinical problem to be solved (e.g., therapeutic target of the Surviving Sepsis Campaign not reached, tissue hypoperfusion), choose a therapy adapted while taking into account the clinical scenario and the results of both the transpulmonary thermodilution and TEE, evaluate the efficacy of this treatment (problem solved or not) and its tolerance (potential side-effect attributable to the treatment). In addition, the presence or resolution of signs of tissue hypoperfusion will systematically be assessed at H6, H12 and H24. Primary and secondary outcomes will be assessed by an independent committee of experts.
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:
|18 Years and older (Adult, Senior)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
Inclusion Criteria:
- ventilated patient in sinus rhythm with septic shock requiring a hemodynamic assessment
Exclusion Criteria:
- < 18 yr-old
- pregnancy
- contra-indication for TEE, non sinus rhythm, aplasia, prior participation to the study, hemodynamic assessment using any other technique than those tested in the study.
Contacts and Locations
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01188993
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01188993
|Contact: Philippe VIGNON, Professor
|Bordeaux UH
|Bordeaux, France, 33 076
|Contact: Frédéric Vargas, Doctor (+33)(0)556795517
|Principal Investigator: Frédéric VARGAS, Doctor
|Toulouse UH
|Toulouse, France, 31 059
|Contact: Michelle GENESTAL, Professor (+33)(0)561772288
|Principal Investigator: Michelle GENESTAL, Professor
Sponsors and Collaborators
University Hospital, Limoges
More Information
Additional relevant MeSH terms:
|Responsible Party:
|University Hospital, Limoges
|ClinicalTrials.gov Identifier:
|NCT01188993 History of Changes
|Other Study ID Numbers:
|First Submitted:
|August 25, 2010
|First Posted:
|August 26, 2010
|Last Update Posted:
|November 1, 2013
|Last Verified:
|August 2010
Additional relevant MeSH terms:
Shock, Septic
Pathologic Processes
Systemic Inflammatory Response Syndrome


text:
The conversation around seed often gets grossly oversimplified to: heirlooms good, GMO's bad. The truth is more complex. Seed Matters advocates for the improvement and protection of organic seed to ensure healthy, nutritious, and productive crops to feed people now and in the future. Turns out it's not just agrichemical companies that are "feeding the world." To educate people about seed issues and the benefits of organic seed we engineered a seed of our own — an organic one that could talk: Mr. Seed. We landed comedian Pete Holmes to voice the character. We attached Buck, a truly rad collaborator, to develop the character, his world and animate the story. The aptly named Antfood brought a wry sensibility to the soundtrack of the film. And after a gajillion hours of rendering time, Mr. Seed blossomed into the foul-mouthed messenger of food truth justice that he was born to be.
"Just like us, The Butler Bros are passionate advocates for organic seed systems. They provide just the kind of creative s**t you need for a great organic campaign."
—Thao Pham, Executive Director of Clif Bar Family Foundation
Spreading the Word
Since Mr. Seed looks more like a new film from Pixar than a cause campaign, we chose to promote it like a movie. We took key moments and images from the film and turned them into bite-sized pieces of content for social media.
Concept by Butler Bros:
Creative Directors: Adam Butler, Marty Butler Art Directors: Allie Nordstrom, Marty Butler Copywriters: Jeremy Spencer, Ryan Honey, Erik Enberg, Adam Butler Designers: Craig Crutchfield, Hoang Nguyen Producers: Vincent Calderon, Bridget Liddy, Christine Lopez
Directed by BUCK:
Executive Creative Director: Ryan Honey Executive Producer: Maurie Enochson Creative Director: Joe Mullen Head of CG: Doug Wilkinson Producer: Emily Rickard Production Coordinator: Kaitlyn Mahoney Art Director: Laura Yilmaz Character Design: Joe Mullen, Kenesha Sneed Storyboards: Laura Yilmaz, Kendra Ryan, Craig Yamamoto Concept Art and Matte Paintings: Laura Yilmaz, Scott Huntsman, Susan Yung Design: Laura Yilmaz, Joe Mullen, Susan Yung, Scott Huntsman, Audrey Lee, Rasmus Bak, Xoana Herrera, Vincent Tsui, Jenny Ko, Kenesha Sneed CG Lead: Alex Dingfelder Modeling: Eric Pagtaconan, Wing Sze Lee, Michele Herrera, John Niehuss, Mingoo Park, Jens Lindgren, Eyad Hussein, Alex Dingfelder, Arvid Volz, Brice Linane, Rie Ito Look Development Lead: Alex Dingfelder Look Development: Wing Sze Lee, Eric Pagtaconan, Michele Herrera, Jens Lindgren, John Niehuss, Mingoo Park Rigging TD: Ernesto Ruiz Velasco Character TD: Eyad Hussein, Ernesto Ruiz Velasco Pipeline and FX TD: Albert Omoss Additional Rigging: Lee Wolland Animation Director: Alessandro Ceglia 3D Animation: Alessandro Ceglia, Tyler Lancaster, Dony Permedi, Adam Floeck 2D Screen Animation: Vincent Tsui, Debora Cruchon, Rafael Araujo, Nicole Stafford Lighting Direction: Alex Dingfelder Lighting: Wing Sze Lee, Jens Lindgren, Alex Dingfelder, Eric Pagtaconan, Michele Herrera Compositing Lead: Alex Dingfelder Compositing: Wing Sze Lee
Pharm Foods Commercial:
Design: Gunnar Pettersson Animation Director: Laura Yilmaz Animation: Laura Yilmaz, Kendra Ryan, Nick Petley, Vincent Tsui, Rafael Araujo, Debora Cruchon, Nicole Stafford
End Credits:
Associate Creative Director: Kevin Walker Design: Rasmus Bak Animation: Rasmus Bak, Esteban Esquivo Music and Sound Design: Antfood Voice of Mr. Seed: Pete Holmes


text:
|Publication number
|Publication type
|Application number
|Publication date
|May 1, 2012
|Filing date
|Jul 21, 2011
|Priority date
|Feb 2, 2009
|Fee status
|Also published as
|Publication number
|Prafulla Masalkar
|Original Assignee
|Microsoft Corporation
|Export Citation
|BiBTeX, EndNote, RefMan
|Patent Citations (18), Non-Patent Citations (6), Referenced by (1), Classifications (6), Legal Events (4)
|External Links: USPTO, USPTO Assignment, Espacenet
This application is a continuation of U.S. patent application Ser. No. 12/363,935, titled "DIFFUSING SCREEN" and filed Feb. 2, 2009, the entire disclosure of which is hereby incorporated by reference.
Diffusing screens are used to redirect light and produce a desired spatial distribution of light intensity from a screen. Light incident on a screen is refracted or reflected as it moves from the screen into another media of transmission (e.g. air). By the use of a screen with a varied surface topography, light is sent in different directions, distributing the light across a range of angles relative to a plane of the screen.
A diffusing screen may be paired with an image source, such as a projection device, to distribute light for a projected image. In such applications, it is often desirable to distribute light evenly across a range of viewing directions relative to the screen. Therefore, diffusing screens are often configured to produce a Lambertian distribution of reflected light or the like.
Various embodiments are disclosed herein that relate to a rear projection display screen configured to reduce an intensity of light at a viewing angle at which the light is less likely to be viewed by a user. For example, one disclosed embodiment provides a diffusing screen comprising a sheet-like structure transparent to one or more wavelengths of light, wherein the sheet-like structure has a viewing surface and comprises a diffusing pattern configured to create destructive interference of a selected wavelength of light traveling in a direction normal to a plane of the viewing surface.
This Summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used to limit the scope of the claimed subject matter. Furthermore, the claimed subject matter is not limited to implementations that solve any or all disadvantages noted in any part of this disclosure.
As described above, many diffusing screens for projection display systems are configured to produce a Lambertian, or other relatively uniform, distribution of transmitted or reflected light. This is because it is desirable in many applications for a projected image to have a similar brightness across a range of viewing angles. As a specific example, a rear projection television with a vertically oriented display screen may have a diffusing screen configured to provide an image of similar light intensity across a range of angles at which viewers may potentially sit in front of the television.
However, in other applications, a display screen may be horizontally oriented. For example, some interactive computing devices may be configured to have a horizontally oriented rear projection screen similar to a table top around which users sit. Because users of such a device view such a display screen predominantly at an angle that is diagonal to the display screen surface plane, light projected in a direction normal to the screen does not reach viewers seated around such a device, and is therefore wasted.
The reduction of such wasted light may lead to various advantages. For example, where a relatively brighter, higher power light source, such as an arc lamp, is employed, reducing such wasted light may lead to more efficient use of power. Likewise, where relatively dimmer, lower power light source, such as an LED array, is used, reducing such wasted light may allow more light to be directed toward viewers, thereby improving the brightness perceived by views.
Therefore, various embodiments are disclosed herein related to a rear projection display screen configured to reduce an intensity of light at a viewing angle at which the light is less likely to be viewed by the user. Before discussing these embodiments in detail, an example device utilizing a horizontal display screen is described.
Display screen 14 may include a clear, transparent portion 20, such as a sheet of glass, and a diffuser, referred to herein as diffuser screen layer 22, disposed over the clear, transparent portion 20. In some embodiments, an additional transparent layer (not shown) may be disposed over diffuser screen layer 22 to provide a smooth look and feel to the display screen. In this way, transparent portion 20 and diffuser screen layer 22 can form a non-limiting example of a touch-sensitive region of display screen 14. It will be understood that the diffuser screen layer may either be a separate part from the clear, transparent portion 20, or may be formed in a surface of, or otherwise integrated with, the clear, transparent portion 20.
Continuing with
To sense objects that are contacting or near to display screen 14, surface computing system 10 may include one or more image capture devices (e.g., sensor 28, sensor 30, sensor 32, sensor 34, and sensor 36) configured to capture an image of the backside of display screen 14, and to provide the image to logic subsystem 24. The diffuser screen layer 22 can serve to reduce or avoid the imaging of objects that are not in contact with or positioned within a few millimeters or other suitable distance of display screen 14, and therefore helps to ensure that at least objects that are touching the display screen 14 are detected by the image capture devices. While the disclosed embodiments are described in the context of a vision-based multi-touch display system, it will be understood that the embodiments may be implemented on any other suitable touch-sensitive display system, including but not limited to capacitive and resistive systems.
The image capture devices may include any suitable image sensing mechanism. Examples of suitable image sensing mechanisms include but are not limited to CCD and CMOS image sensors. Further, the image sensing mechanisms may capture images of the display screen 14 at a sufficient frequency or frame rate to detect motion of an object across the display screen 14. In other embodiments, a scanning laser may be used in combination with a suitable photodetector to acquire images of the display screen 14. Display screen 14 may alternatively or further include an optional capacitive, resistive or other electromagnetic touch-sensing mechanism, which may communicate touch input to the logic subsystem via a wired or wireless connection 38.
The image capture devices may be configured to detect reflected or emitted energy of any suitable wavelength, including but not limited to infrared and visible wavelengths. To assist in detecting objects placed on display screen 14, the image capture devices may further include an illuminant, such as one or more light emitting diodes (LEDs).
In some examples, one or more of infrared light source 90 and/or infrared light source 42 may be positioned at any suitable location within surface computing system 10. In the example of
It will be understood that the surface computing device 10 may be used to detect any suitable physical object, including but not limited to, fingers, styluses, cell phones, cameras, other portable electronic consumer devices, barcodes and other optically readable tags, etc.
As described above, the use of a diffusing screen with a Lambertian distribution of transmitted light intensities may result in light transmitted along directions not ordinarily viewed by a user 200 seated at the surface computing device 10. Therefore, the diffuser screen layer 22 may comprise such a diffusing screen and be configured to create destructive interference of selected wavelengths of visible light from the light source along such directions.
For example, in the depicted embodiment, if a Lambertian diffusing screen were used as the diffuser screen layer 22 of surface computing device 10, a substantial portion of the light emitted from and/or transmitted through the viewing surface 230 would be projected in a direction normal to a plane of the display screen 240 and/or viewing surface 230 (i.e., along direction N). However, as depicted in
Therefore, to reduce an amount of light transmitted in directions not ordinarily viewed by a user of the surface computing device 10, the diffuser screen layer 22 may comprise a diffusing pattern configured to create destructive interference of selected wavelengths of light traveling in the direction N, normal to the plane of the viewing surface 230.
The diffusing pattern of the viewing surface 230 may be configured according to the nature of the image source. For example, when the image source comprises an arc lamp, the diffusing pattern may be configured to create destructive interference across a distribution of wavelengths of light centered, for example, on a peak green light having a wavelength between 520 nanometers (nm) and 590 nm In further examples, when the image source comprises a plurality of LEDs, the diffusing pattern may be configured to create destructive interference around each of three wavelengths of light corresponding to three colors (e.g., red, green and blue).
Further still, the diffusing pattern may be configured to create constructive interference of an image by creating constructive interference for one or more wavelengths of visible light within a range of angles (e.g., angle range V). In some embodiments, the angle range may be a distribution from a first angle to a second angle (e.g. 15 degrees from the viewing surface 230 to 75 degrees), and may be centered about an angle at which a maximum intensity is desired. In one specific embodiment, the angle range may be a lobe or bell distribution centered on a maximal angle of 51 degrees from the viewing surface 230. It will be understood that in alternate configurations, the angle ranges and diffusing pattern configuration may vary according to, for example, an expected location of the user, configuration and orientation of the viewing surface 230, and the like, and that destructive and constructive interference may be created at any suitable angles relative to a plane of the viewing surface.
The diffuser screen layer 22 may have any suitable structure configured to create destructive interference of selected wavelengths of light traveling in a direction normal to a plane of the viewing surface. For example, in some embodiments, the diffusing pattern may comprise a plurality of pattern elements. The pattern elements may be arranged to create destructive interference along the direction N by various mechanisms, including but not limited to diffraction elements and/or viewing surface topography elements. In some embodiments, the diffusing pattern may comprise a terraced topography that exists at a boundary between two media of different indices of refraction, such as the screen and air, or two or more different screen materials. Further, in some embodiments, the diffusing pattern may be formed in or embedded within the sheet-like structure of the display screen 240, while in other embodiments, the diffusing pattern may be formed on the viewing surface 230, or a surface of the diffuser screen layer 22 opposite the viewing surface. Further examples of such embodiments are described herein below.
Each pattern element may have any suitable dimensions. For example, it may be desirable to have pattern elements of a sufficiently small size not to be visible to a view sitting an average viewing distance from the screen during use. In some embodiments, individual pattern elements may have a feature size 312 of between 0.1 and 0.4 microns. Other embodiments may have either larger or smaller feature sizes than this range.
The location and spatial arrangement of the first terrace relative to the second terrace may vary for each element in a pseudo-random arrangement when viewed from the top down (as shown in
The first terrace 320 and second terrace 330 may have any suitable relative surface areas. For example, in some embodiments, a surface area of the first terrace 320 is equal to a surface area of the second terrace 330. In other embodiments, the first terrace 320 and second terrace 330 may have different surface areas, depending upon a desired magnitude of destructive interference to be achieved. Further, in some embodiments, a sum of the surface areas of all first terraces 320 may be equal to a sum of all of the surface area of second terraces 330, while in other embodiments these sums may not be equal.
Turning now to
Light 460 travelling normal to an example viewing surface is transmitted through the first terrace 320 and the second terrace 330. A first example light ray 462 having the selected wavelength is shown with phase 464. A second example light ray 466 having the selected wavelength is shown with phase 468. The phases of the two rays add to zero, for example, along dashed line 480. The transition height may be tuned so that a desired wavelength may undergo destructive interference at a desired wavelength in the manner described above. In this way, a diffusing pattern may create destructive interference for light of a selected wavelength of light traveling normal to the viewing surface. Further, such a pattern also may create constructive interference in a direction toward a viewer, thereby increasing an apparent intensity of the light to the viewer.
The location of the first terrace relative to the second and third terraces may vary for each pattern element (and, similarly, the location of the second terrace relative to the first and third) so that the elements may form a pseudo-random arrangement when viewed from the top down (as shown in
The first terrace 520, second terrace 530 and third terrace 540 may have any suitable relative surface areas. For example, in some embodiments, a surface area of a sum of the first terrace 520 and third terrace 540 is equal to a surface area of the second terrace 530. In other embodiments, relative surface areas of the first terrace 520, second terrace 530 and third terrace 540 may have any other suitable values, depending upon a desired magnitude of destructive interference. Likewise, in some embodiments, a sum of the surface areas of all first terraces 520 and third terraces 540 across the diffusing screen may be equal to a sum of the surface areas of all second terraces, while in other embodiments these sums may not be equal.
Turning now to
The depicted transition 650 and 652 comprises a step substantially parallel to the normal direction. In other embodiments, the transitions may comprise a slope between terraces that is not parallel to the normal direction. Further still in some examples, the transitions 650 and 652 may correspond to different wavelengths, further randomizing the diffusing pattern of such examples.
Continuing with
While the first, second and third terraces are shown as spatially sequential in the depicted embodiments, in other embodiments, these structures may not be spatially sequential. For example, the second terrace (i.e. the terrace having an intermediate height) may be farther from the first terrace than the third terrace.
The screen surface topographies described above may be formed in any suitable manner. For example, in one embodiment, such terraced topographies may be formed by the rolling of a master on a optical material, for example, during solidification of a glass or polymerization, cross-linking, and/or solidification of a polymer. Further, such a topography also may be formed via casting, various molding techniques, etching, etc.
The topologies described with reference to
While disclosed herein in the context of a horizontal rear projection display system, it will be understood that the diffusing screens described herein also may be used with suitable front projection systems, and/or with display systems having screens oriented at any other suitable angle, including but not limited to vertical screens.
The diffuser screen layer 702 may further optionally comprise a lenticular lens array 710 positioned below the diffuser 706 to help reject ambient light and improve image contrast. In some embodiments, a microlens array may be used in place of or in addition to the lenticular lens array. Further, in various embodiments, the display screen system 700 also may optionally include a Fresnel lens structure 712, an anti-reflective coating 714, and/or any other suitable structures.
While disclosed herein in the context of specific example embodiments, it will be appreciated that the configurations and/or approaches described herein are exemplary in nature, and that these specific embodiments or examples are not to be considered in a limiting sense, because numerous variations are possible. The subject matter of the present disclosure includes all novel and nonobvious combinations and subcombinations of the various processes, systems and configurations, and other features, functions, acts, and/or properties disclosed herein, as well as any and all equivalents thereof
|Cited Patent
|Filing date
|Publication date
|Feb 27, 1974
|Sep 30, 1975
|Rca Corp
|Controlled angle viewing screens by interference techniques
|Jun 3, 1981
|Feb 8, 1983
|Hughes Aircraft Company
|Directional diffusing screen
|Jul 5, 1988
|Oct 2, 1990
|Hughes Aircraft Company
|Diffraction optics diffusing screen laminate for full color on-axis viewing
|Jul 9, 1992
|Jan 18, 1994
|Honeywell Inc.
|Directional diffuser for a liquid crystal display
|Sep 23, 1998
|Apr 4, 2000
|U.S. Philips Corporation
|Image projection screen having diffuser to spread light
|Dec 19, 1996
|May 9, 2000
|Fujimoto; Kenneth Noboru
|Integrated computer display and graphical input apparatus and method
|Sep 25, 1998
|Sep 5, 2000
|Dai Nippon Printing Co., Ltd.
|Transmission screen system
|Oct 10, 2000
|Dec 4, 2001
|Philips Electronics North America Corporation
|Rear projection screen with reduced speckle
|Apr 26, 2000
|Oct 15, 2002
|3M Innovative Properties Company
|Rear projection screen with reduced speckle
|Jul 27, 2002
|May 11, 2004
|San Zhuang Wang
|Backlighting system for displays
|May 14, 2002
|Sep 14, 2004
|International Business Machines Corporation
|Direct view display with lenticular lens for improved brightness and wide viewing angle
|Jan 21, 2004
|Apr 25, 2006
|Asml Netherlands B.V.
|Optical element, lithographic apparatus comprising such optical element and device manufacturing method
|Mar 17, 2004
|Aug 29, 2006
|Mitsubishi Denki Kabushiki Kaisha
|Diffuser panel for rear projection screen and such rear projection screen
|Sep 9, 2004
|Mar 4, 2008
|Lumas Ltd.
|High brightness optical device
|Dec 16, 2004
|Apr 22, 2008
|Hitachi, Ltd.
|Screen, Fresnel lens sheet used for the same, and image display apparatus using the same
|Apr 19, 2006
|Sep 30, 2008
|Wavefront Technology, Inc.
|Elliptical diffusers used in displays
|May 8, 2006
|Nov 9, 2006
|Vesely Michael A
|Three dimensional horizontal perspective workstation
|Oct 11, 2006
|Jun 14, 2007
|Bose Corporation, A Delaware Corporation
|Selective reflecting
|"Holographic Diffusers can Efficiently and Cost Effectively Distribute Light", Retrieved at<<http://statusreports.atp.nist.gov/reports/93-01-0205PDF.pdf>>, pp. 5.
|"Holographic Diffusers can Efficiently and Cost Effectively Distribute Light", Retrieved at>, pp. 5.
|Takaki Yasuhiro, "Three-Dimensional Display with 64 Horizontal Parallaxes", Retrieved at<<http://firstname.lastname@example.com>>, pp. 4.
|Takaki Yasuhiro, "Three-Dimensional Display with 64 Horizontal Parallaxes", Retrieved at<<http://tfcg.elis.ugent.be/student/scripties/2008/polyscopic/Artikels/Takaki@ASID2002—S2-094.pdf>>, pp. 4.
|Wood, et al. "Impact of Screen Construction on Sharpness and Contrast in MDTV Displays", Retrieved at<<http://www.brightviewtechnologies.com/downloads/mtf-whitepaper06—20.pdf>>, "Bright View Technologies", pp. 1-6.
|Wood, et al. "Impact of Screen Construction on Sharpness and Contrast in MDTV Displays", Retrieved at>, "Bright View Technologies", pp. 1-6.
|Citing Patent
|Filing date
|Publication date
|Feb 29, 2008
|Sep 3, 2009
|Microsoft Corporation
|Interactive Surface Computer with Switchable Diffuser
|U.S. Classification
|International Classification
|Cooperative Classification
|European Classification
|Dec 9, 2014
Owner name: MICROSOFT TECHNOLOGY LICENSING, LLC, WASHINGTON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MICROSOFT CORPORATION;REEL/FRAME:034544/0001
Effective date: 20141014
|Dec 11, 2015
|Maintenance fee reminder mailed
|May 1, 2016
|Lapse for failure to pay maintenance fees
|Jun 21, 2016
|Expired due to failure to pay maintenance fee
Effective date: 20160501


text:
We will help you find a home sociology tutor in Halstead and anywhere in the UK. Local sociology tuition is an excellent way to bolster confidence as well as increasing grades and doesn't have to be dull! Please use our service to search for Halstead sociology tutors and select which best suits your requirements.
First Tutors is the only place to find the top Halstead sociology tutors for your needs, enabling you to find a local Halstead sociology teacher for any subject including GCSE English, A-Level Maths or even university Economics. We also help with language tuition, so if you want to learn Italian, take a Russian course or prepare yourself for Spanish life, we can help - and all in Halstead! We order sociology Halstead teachers in your area by sociology lesson costs and proximity to you.
If you are a Halstead sociology tutor wanting to offer your private sociology tuition services in Halstead or anywhere else across the UK, please register with First Tutors or find out more about what we do here. Private sociology tuition is a great way to re-affirm your own sociology knowledge while helping someone else, all in the Halstead area!


text:
Art of Drawing: Flowers, Fruit & Vegetables : Simple Approaches to Drawing Natural Forms Paperback
by Giovanni Civardi
Part of the Art of Drawing series
Giovanni Civardi has built a formidable reputation worldwide for his skills as both an artist and a teacher, and here he provides a unique introduction to the art of still-life drawing focusing on natural forms.
The focus of the book is very much on Giovanni's exquisite drawings of a broad range of flowers, fruit and vegetables, which are accompanied by concise, clearly written explanations of perspective, composition, vegetable anatomy and structure, and light and shade.
At the start of the book there is a useful section on the various drawing materials that are available, where to find botanical subjects and how to make careful studies and observation.
The author's in-depth knowledge of the subject is apparent throughout, making this book an ideal introduction for the beginner, as well as a source of information and inspiration for artists of all abilities.
- Format: Paperback
- Pages: 64 pages, 160 Illustrations, black and white
- Publisher: Search Press Ltd
- Publication Date: 15/09/2011
- Category: Drawing & drawings
Free Home Delivery
on all orders
Pick up orders
from local bookshops


text:
About Group
No activity in last 7 days
Group Description
The RANDALL Mailing List is for all those who are researching the RANDALL surname, any time anywhere any place. So come, join us, and share your RANDALL Families history! International contact and genealogical research about RANDALL and related names very welcome.
Group Information
- 67
- Genealogy
- Apr 4, 1999
- English
Group Settings
- This is a public group.
- Attachments are permitted.
- Members cannot hide email address.
- Listed in Yahoo Groups directory.
- Membership does not require approval.
- Messages are not moderated.
- All members can post messages.


text:
If you are searching for a job as an executive or CEO, it's important to follow best practices for executive cover letters, including proper formatting and language. Many employers are using applicant tracking systems (ATS) to sort and screen job applications, so using a writing service that specializes in executive cover letters, like TopResume, can ensure your application sails through those systems – and doesn't get tossed in the trash.
As you apply to executive or CEO positions, it's important to avoid cover letter mistakes that could ruin your chances. Such errors include:
Do you have the cover letter that will avoid the trash pile and get you the interview? You can. Two of our resume packages (Career Evolution and Executive Priority) include cover letter writing. We guarantee you'll get 2x more job interviews within 60 days or we'll rewrite your resume for free.
The better the cover letter, the more likely the interview. Use our executive cover letter writing service today!
What are you waiting for?
Land more interviews at better companies, with a professionally written resume from TopResume. We guarantee 2x more job interviews within 60 days or we'll rewrite your resume for free.